Vinicius Agibert
Editorial Board Member
Oncologist at CTO - Petropolis CEO and Co-founder LaVi Clinical Trials Ambassador - Thummi
Brazil
Dr. Stefany Faria
Editorial Board Member
Clinical Oncologist at CPO (Centro Paulista de Oncologia) - Faria LIma
Brazil
Reema Al Hayek
Editorial Board Member
Director Medical Services Center at KFSHD
Saudi Arabia
Dr Trinanjan Basu
Editorial Board Member
Consultant Radiation Oncologist - HCG Cancer Centre
Mumbai, India
Dr Neeraj Jain
Editorial Board Member
Professor, Dept. of Radiotherapy & amp Oncology,
India
Dr. Sukhminder Jit Singh Bajwa
Editorial Board Member
Professor and Head, Anaesthesiology & Critical Care, Gian Sagar Medical College & Hospital
Punjab, India
Mukesh S
Editorial Board Member
Associate Professor, Radiation Oncologist at Mysore Medical College and Research Institute
Mysore, India
Dr Mohamed Ahmed Mohamed Nagy Mohamed
Editorial Board Member
Head of Clinical Pharmacy Department El Minia Hospital for Mental health and addiction treatment Private Work - Dr Mohamed Nagy Diagnostic Lab
El Minia, Egypt
Publishing in open access Journals makes your work freely and permanently available online for anyone, anywhere. Paying for access to articles to each reader requires the production of physical copies, but through open access, it is easy to distribute and access all over the world.
Benefits for publishing with Journal with us – Open Access
- High prominence
- Authors can retain copyright
- Publications are freely accessible online
- Prominent peer review, production and publishing processes
Momentera Journals on Cancer is an open access, peer-reviewed journal with broad scope covering all areas of cancer research, especially novel concepts, new methods, new regimens, new therapeutic agents, and alternative approaches for early detection and intervention of cancer. The Journal is supported by an international editorial board consisting of a distinguished team of cancer researchers. The journal welcomes research across all cancer types and aims at rapid publication of high-quality results in cancer research while maintaining rigorous peer-review process.